BioCryst公司的贝罗司他胶囊药品说明书

BioCryst's drug instructions:

【Indications】

Berostat capsule Orladeyo is a plasma kallikrein inhibitor. Berostat capsule Orladeyo can prevent hereditary angioedema (HAE) in adults and pediatric patients over 12 years of age.

【Usage and Dosage】

Recommended dosage of Orladeyo: take one capsule (150 mg) once daily with food. Patients should not increase or decrease the dosage of the drug without authorization during treatment with Orladeyo. Increasing the dosage of the drug will not make the condition improve quickly, but will lead to adverse reactions. Therefore, patients should strictly follow the doctor's diagnosis and treatment recommendations and should not use medication without authorization.

【Adverse reactions】

The most common adverse reactions of Berostat capsule Orladeyo include: abdominal pain/vomiting/diarrhea/back pain/gastroesophageal reflux disease, etc.

【Notes】

Patients who take more than one Orladeyo capsule a day may experience QT prolongation, a condition that can lead to abnormal heartbeats.

Patients should be informed that Berosostat capsules Orladeyo may interact with other medications. And patients are advised to report the use of any other prescription or over-the-counter medications or herbal products to their physician.

Patients who are allergic to any of the ingredients in Berostat capsule Orladeyo should not use this drug for treatment.

Berostat capsules Orladeyo should not be used to treat acute attacks of hereditary angioedema (HAE).

Orladeyo is not indicated for the acute treatment of acute ischemic encephalopathy attacks: Advise patients to take commonly used rescue medications for the treatment of acute ischemic encephalopathy attacks. Patients should be informed that the safety and effectiveness of Orladeyo as an acute treatment for hereditary angioedema HAE attacks have not been established.

Recommended related hot articles: /newsDetail/96493.html

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.